Advertisement
Singapore markets close in 2 hours 22 minutes
  • Straits Times Index

    3,299.81
    +27.09 (+0.83%)
     
  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     
  • Hang Seng

    17,169.08
    +340.15 (+2.02%)
     
  • FTSE 100

    8,044.81
    +20.94 (+0.26%)
     
  • Bitcoin USD

    66,646.79
    +100.19 (+0.15%)
     
  • CMC Crypto 200

    1,413.89
    -10.21 (-0.72%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • Dow

    38,503.69
    +263.71 (+0.69%)
     
  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     
  • Gold

    2,339.90
    -2.20 (-0.09%)
     
  • Crude Oil

    83.50
    +0.14 (+0.17%)
     
  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     
  • FTSE Bursa Malaysia

    1,568.59
    +6.95 (+0.45%)
     
  • Jakarta Composite Index

    7,168.54
    +57.73 (+0.81%)
     
  • PSE Index

    6,581.24
    +74.44 (+1.14%)
     

Why Catalent Stock Slumped on Monday

Why Catalent Stock Slumped on Monday

Contract drug manufacturer Catalent (NYSE: CTLT) was surely tempted to reach for the aspirin bottle on Monday. Bloomberg reported that morning that the conglomerate Danaher (NYSE: DHR) has dropped its pursuit of Catalent. Citing "people familiar with the matter," the Bloomberg report said Danaher is no longer considering making a buyout offer despite its earlier expression of interest.